Healthcare Newsletter – December 2022 Edition

Healthcare Newsletter – December 2022 Edition

This edition of the JSA Healthcare Newsletter covers recent notifications and orders issued by the Ministry of Health and Family Welfare, Central Drugs Standard Control Organisation, Department of Pharmaceuticals. Some of the significant developments include:

  • Registration of medical devices testing laboratories;
  • Inspection/audits of pharmacovigilance system of importers and manufacturers of human vaccine;
  • Joint inspection of drug manufacturing units for compliance under the Drugs and Cosmetics Act, 1940 and rules thereunder; and

To read further details, click here or refer to the below document.

 

For more details, please contact [email protected]

*In case the document is not visible on the device you are using, please click the link above.

Newsletters & Updates

  • JSA Prism
  • February 26, 2024

Easing of FDI norms in the space sector

  • Newsletters
  • February 22, 2024

Insurance Law | Annual Compendium 2023

  • JSA Prism
  • February 19, 2024

JSA Prism | Employment | February 2024

View More